Millstone Evans Group’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.65K Buy
+75
New +$3.65K ﹤0.01% 618